Table 2 Symptom recurrences according to patient and treatment characteristics in patients with palliative symptom control after palliative treatment.
From: Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer
Characteristic | Total control number | Recurrence (%) | p-value |
|---|---|---|---|
Symptom | Â | Â | Â |
Pain | 33 (49) | 35 (51) | 0.1499 |
Bleeding | 13 (72) | 5 (28) | Â |
Obstruction | 6 (67) | 3 (33) | Â |
Re-irradiation | Â | Â | Â |
Yes | 16 (53) | 14 (47) | 0.8519 |
No | 36 (55) | 29 (45) | Â |
Biologically equivalent dose | Â | Â | Â |
< 40 Gy10 | 11 (32) | 23 (68) | 0.0011 |
≥40 Gy10 | 41 (67) | 20 (33) |  |
Concurrent chemotherapy | Â | Â | Â |
Yes | 14 (44) | 8 (36) | 0.3387 |
No | 38 (52) | 35 (48) | Â |